Solara Active Pharma Sciences Overview
- Year Founded
-
2017
- Status
-
Public
- Employees
-
3,108
- Stock Symbol
-
541540
- Investments
-
3
- Share Price
-
$6.74
- (As of Friday Closing)
Solara Active Pharma Sciences General Information
Description
Solara Active Pharma Sciences Ltd is an Active Pharmaceutical Ingredients company engaged in the development and manufacture of APIs and providing CDMO services to pharmaceutical companies. The Company operates through six multi-product manufacturing facilities and is engaged in the manufacture and sale of Active Pharma Ingredients. Its products include Anthelmintic, Anticonvulsant, Loop Diuretic, Anxiolytic, Antihistamine, Antipsychotic, Calcimimetic Agent, Antigout Agent, Anti-hyperlipidemic, and others. The Company generates maximum revenue from Asia Pacific.
Contact Information
Website
www.solara.co.inCorporate Office
- 3rd & 4th Floor, Batra Centre, No.28, Sardar Patel Road
- Guindy
- Chennai, Tamilnadu 600032
- India
Corporate Office
- 3rd & 4th Floor, Batra Centre, No.28, Sardar Patel Road
- Guindy
- Chennai, Tamilnadu 600032
- India
Solara Active Pharma Sciences Stock Performance
As of 20-Nov-2026, Solara Active Pharma Sciences’s stock price is $6.74. Its current market cap is $325M with 48.3M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $6.74 | $6.84 | $4.46 - $8.08 | $325M | 48.3M | 22.7K | $0.08 |
Solara Active Pharma Sciences Financials Summary
As of 30-Sep-2026, Solara Active Pharma Sciences has a trailing 12-month revenue of $166M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 430,346 | 263,500 | 348,469 | 276,772 |
| Revenue | 165,579 | 150,531 | 146,819 | 149,590 |
| EBITDA | 24,951 | 18,985 | 23,912 | (34,727) |
| Net Income | 3,984 | (839) | 64 | (68,537) |
| Total Assets | 255,502 | 247,221 | 260,914 | 281,912 |
| Total Debt | 61,565 | 72,765 | 93,066 | 121,292 |
Solara Active Pharma Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Solara Active Pharma Sciences Comparisons
Industry
Financing
Details
Solara Active Pharma Sciences Competitors (20)
One of Solara Active Pharma Sciences’s 20 competitors is Aarti Drugs, a Corporation company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aarti Drugs | Corporation | Mumbai, India | ||||
| Neuland Laboratories | Corporation | Hyderabad, India | ||||
| Jubilant Pharmova | Corporation | Noida, India | ||||
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Divi's Laboratories | Corporation | Hyderabad, India |
Solara Active Pharma Sciences Patents
Solara Active Pharma Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020039449-A1 | An improved process for the preparation of obeticholic acid and intermediates used in the process thereof | Inactive | 24-Aug-2018 | ||
| US-20210261599-A1 | Process for the preparation of obeticholic acid and intermediates used in the process thereof | Inactive | 24-Aug-2018 | ||
| US-11142603-B2 | Process for preparation of patiromer | Inactive | 16-May-2018 | ||
| US-20190352442-A1 | Process for preparation of patiromer | Active | 16-May-2018 | ||
| WO-2019220450-A1 | Process for preparation of patiromer | Inactive | 16-May-2018 | C08F220/22 |
Solara Active Pharma Sciences Signals
Solara Active Pharma Sciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Solara Active Pharma Sciences Investments & Acquisitions (3)
Solara Active Pharma Sciences’s most recent deal was a Merger/Acquisition with Aurore Life Sciences. The deal was made on 01-Apr-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Aurore Life Sciences | 01-Apr-2021 | Merger/Acquisition | Pharmaceuticals | ||
| SeQuent Penems | 03-Feb-2021 | Secondary Transaction - Private | Other Pharmaceuticals and Biotechnology | ||
| Strides Chemicals | 01-Sep-2018 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Solara Active Pharma Sciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Solara Active Pharma Sciences Exits (1)
Solara Active Pharma Sciences’s most recent exit was on 03-Feb-2021 from SeQuent Penems. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| SeQuent Penems | 03-Feb-2021 | Completed |
|
Solara Active Pharma Sciences Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Aurore Life Sciences | Hyderabad, India | 2017 |
Solara Active Pharma Sciences FAQs
-
When was Solara Active Pharma Sciences founded?
Solara Active Pharma Sciences was founded in 2017.
-
Where is Solara Active Pharma Sciences headquartered?
Solara Active Pharma Sciences is headquartered in Chennai, India.
-
What is the size of Solara Active Pharma Sciences?
Solara Active Pharma Sciences has 3,108 total employees.
-
What industry is Solara Active Pharma Sciences in?
Solara Active Pharma Sciences’s primary industry is Biotechnology.
-
Is Solara Active Pharma Sciences a private or public company?
Solara Active Pharma Sciences is a Public company.
-
What is Solara Active Pharma Sciences’s stock symbol?
The ticker symbol for Solara Active Pharma Sciences is 541540.
-
What is the current stock price of Solara Active Pharma Sciences?
As of 20-Nov-2026 the stock price of Solara Active Pharma Sciences is $6.74.
-
What is the current market cap of Solara Active Pharma Sciences?
The current market capitalization of Solara Active Pharma Sciences is $325M.
-
What is Solara Active Pharma Sciences’s current revenue?
The trailing twelve month revenue for Solara Active Pharma Sciences is $166M.
-
Who are Solara Active Pharma Sciences’s competitors?
Aarti Drugs, Neuland Laboratories, Jubilant Pharmova, Evonile Pharma, and Divi's Laboratories are some of the 20 competitors of Solara Active Pharma Sciences.
-
What is Solara Active Pharma Sciences’s annual earnings per share (EPS)?
Solara Active Pharma Sciences’s EPS for 12 months was $0.08.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process